Work Package 5 


WP5: Screening of potential chemotherapeutic agents for brain cancer -- Leader: PPS (M24-M48)
WP5 includes the tasks that aim to: assess the BBB penetration and anti-tumour efficacy of a number of CNS and non-CNS penetrating chemotherapeutics with and without the micro/nano-particles in in vivo model of brain cancer